Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2020

View Archived Issues

Linking two liver cancer culprits

Functional analysis complements sequencing

Cerevance presents phase Ib data on CVN-058 for schizophrenia cognition

Lundbeck identifies new Kv3.1 potassium channel activators

Designed Cells, Chungbuk National University patent stem cell-derived exosome-rich culture medium

New phenothiazine derivative antibacterials discovered at the University of Copenhagen

Osaka University presents new histone demethylase inhibitors

New alpha-2B adrenoceptor antagonists described by Bayer

First-in-human PK data presented for ZM-H1505R, a novel HBV capsid assembly modulator

Positive 12-month data for AAV-RPGR in X-linked retinitis pigmentosa

Ependymomas may respond to PARP inhibitors

Biological E's novel COVID-19 subunit vaccine candidate enters phase I/II development

First-in-human interim results of ALN-AGT01 in patients with hypertension

Kangpu opens phase Ib/IIa study to evaluate KPG-818 in SLE

Inovio opens phase II segment of phase II/III study evaluating COVID-19 vaccine candidate INO-4800

Artelo receives clearance for phase I/II trial of ART-27.13 in cancer anorexia

FDA clears IND application for phase II study of NT-I7 plus atezolizumab in NSCLC

Phase III trial shows efficacy and safety of intravenous immunoglobulin in treating dermatomyositis

Innovent presents phase I data on IBI-302 for neovascular AMD

Bispecific 4-1BBx5T4 antibody ALG.APV-527 advancing towards clinic

IBI-188 does not show single-agent activity in phase I study, warrants further combination studies

Tofacitinib demonstrates long-term safety and efficacy in refractory dermatomyositis

FDA clears initiation of phase II trials of NBTXR-3 in HNSCC

TrippBio reports viral clearance in trial of TD-213 for mild to moderate COVID-19

HMGXB4 correlates with vascular inflammation and SMC phenotypic switching

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...